Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Sept 2026 for HALOZYME THERAPEUTICS INC, €3.2M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Matthew Posard: trading record in brief
Our data holds just one disclosure by Matthew Posard, dated 16 September 2026, reporting a transaction worth €3.2M in Halozyme Therapeutics, Inc. Further filings will be added here. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Matthew Posard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 34,226 shares@ US$106.25CommonSEC144:0001950047-26-009587
1 of 1 declaration
